Cargando…

A single centre experience of prosthetic joint infection outcomes with outpatient parenteral antimicrobial therapy

OBJECTIVES: Prosthetic joint infection (PJI) is a serious complication following arthroplasties. This study assessed the clinical outcomes, readmission rates and financial impact of PJIs treated with outpatient parenteral antimicrobial therapy (OPAT). METHODS: The study used prospectively collected...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kutubi, Abdubadie, O'Brien, Luke, Murphy, Ben, Fitzpatrick, Patricia, Hurson, Conor, Rajendran, Deepa, Feeney, Eoin, Mallon, Patrick, Waqas, Sarmad
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2023
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10126847/ https://www.ncbi.nlm.nih.gov/pubmed/37113779 http://dx.doi.org/10.1016/j.heliyon.2023.e15212

Ejemplares similares

Discharge-delaying factors for patients suitable for outpatient parenteral antimicrobial therapy (OPAT) in an Irish tertiary hospital during COVID-19
por: Staunton, S, et al.
Publicado: (2021)

Assessing the Impact of COVID-19 on Overdose Presentations Through the Emergency Department in a Large Tertiary Hospital
por: Saleh, Raneem, et al.
Publicado: (2022)

1944. Patients With Prosthetic Joint Infections Receiving Outpatient Parenteral Antimicrobial Therapy: Characteristics and Readmission Rates
por: Gore, Sara, et al.
Publicado: (2018)

Once-daily tigecycline for outpatient parenteral antibiotic therapy: a single-centre observational study
por: Hughes, Stephen, et al.
Publicado: (2019)

OPAT: outpatient parenteral antimicrobial therapy
Publicado: (2020)

Outpatient parenteral antimicrobial therapy in Brazil
por: Oliveira, Priscila R, et al.
Publicado: (2023)

Prolonged Use of Oritavancin for Vancomycin-Resistant Enterococcus faecium Prosthetic Valve Endocarditis
por: Johnson, Jennifer A., et al.
Publicado: (2015)

HIV and HAART-Associated Dyslipidemia
por: Feeney, Eoin R, et al.
Publicado: (2011)

1935. Outpatient Parenteral Antimicrobial Therapy in Nonagenarians
por: Blaskewicz, Caitlin, et al.
Publicado: (2018)

Safety of Outpatient Parenteral Antimicrobial Therapy in Nonagenarians
por: Shrestha, Nabin K, et al.
Publicado: (2020)

Recommendations for outpatient parenteral antimicrobial therapy in Brazil
por: Oliveira, Priscila R., et al.
Publicado: (2017)

Outpatient parenteral antimicrobial therapy for leishmaniasis: 13 years’ experience at a large UK infectious diseases centre
por: Parkash, Vivak, et al.
Publicado: (2023)

750 Effectiveness, Safety, and Impact on Healthcare Decongestion by a Busy Canadian Infusion Centre for Outpatient Parenteral Antimicrobial Therapy
por: Afra, Kevin, et al.
Publicado: (2014)

Outpatient parenteral antibiotic therapy (OPAT) for the management of bronchiectasis
por: Tu, Jacky, et al.
Publicado: (2023)

Surgeons are deeply affected when patients are diagnosed with prosthetic joint infection
por: Mallon, Charlotte, et al.
Publicado: (2018)

Managing an outpatient parenteral antibiotic therapy team: challenges and solutions
por: Halilovic, Jenana, et al.
Publicado: (2014)

Outpatient parenteral antimicrobial therapy (OPAT) in patients with cystic fibrosis
por: Pedersen, Maya Graham, et al.
Publicado: (2015)

Health-Related Quality of Life in Outpatient Parenteral Antimicrobial Therapy
por: Keller, Sara C, et al.
Publicado: (2018)

Risk Factors for Readmission in Patients with Outpatient Parenteral Antimicrobial Therapy
por: Huang, Victoria, et al.
Publicado: (2017)

1933. Economic Evaluation of Outpatient Parenteral Antimicrobial Therapy in Children
por: Krah, Nathan, et al.
Publicado: (2018)

Perspectives of Patients on Outpatient Parenteral Antimicrobial Therapy: Experiences and Adherence
por: Hamad, Yasir, et al.
Publicado: (2020)

First Pediatric Outpatient Parenteral Antibiotic Therapy Clinic in Indonesia
por: Hendarto, Aryono, et al.
Publicado: (2020)

Recent Updates in Antimicrobial Stewardship in Outpatient Parenteral Antimicrobial Therapy
por: Mahoney, Monica V., et al.
Publicado: (2021)

Outpatient Parenteral Antimicrobial Therapy for Infective Endocarditis—Model of Care
por: Rajaratnam, Dylan, et al.
Publicado: (2023)

Identification of Distinct Long COVID Clinical Phenotypes Through Cluster Analysis of Self-Reported Symptoms
por: Kenny, Grace, et al.
Publicado: (2022)

Patient outcomes following home-based outpatient parenteral antimicrobial therapy and facility-based outpatient parenteral antimicrobial therapy: a systematic review and meta-analysis
por: Hasegawa, Shinya, et al.
Publicado: (2023)

Assessment of ceftolozane/tazobactam stability in elastomeric devices and suitability for continuous infusion via outpatient parenteral antimicrobial therapy
por: Jamieson, Conor, et al.
Publicado: (2021)

Safety and Effectiveness of Outpatient Parenteral Antimicrobial Therapy (OPAT) in the Aged Population
por: Van Anglen, Lucinda J, et al.
Publicado: (2017)

Safety of Nurse- and Self-Administered Paediatric Outpatient Parenteral Antimicrobial Therapy
por: Sriskandarajah, Shanthy, et al.
Publicado: (2020)

Real‐world dosing characteristics and utilization of parenteral treprostinil in the outpatient setting
por: Balasubramanian, Vijay P., et al.
Publicado: (2022)

Improving the safety of outpatient parenteral antimicrobial therapy for patients with solid tumors
por: Robins, Alison, et al.
Publicado: (2021)

A broader view on outpatient parenteral antibiotic therapy (OPAT) stewardship
por: Hess, Danielle, et al.
Publicado: (2022)

Assessment of risk factors associated with outpatient parenteral antimicrobial therapy complications
por: Kaul, Christina, et al.
Publicado: (2022)

Safety and feasibility of outpatient parenteral antimicrobial therapy for patients with spinal infection
por: Kilinc, Fatma, et al.
Publicado: (2023)

Effectiveness of outpatient parenteral antimicrobial therapy (OPAT) for patients with cranial infection
por: Kilinc, Fatma, et al.
Publicado: (2023)

Pushing the agenda for intravenous push administration in outpatient parenteral antimicrobial therapy
por: Johnson, Tanner M., et al.
Publicado: (2023)

330. Outpatient Parenteral Antimicrobial Therapy in People who Inject Drugs
por: Hawes, Armani, et al.
Publicado: (2023)

353. Outpatient parenteral antimicrobial therapy (OPAT) in managing vertebral osteomyelitis
por: Villacorta Cari, Evelyn, et al.
Publicado: (2023)

Clinical and Economic Impact of Implementing OVIVA Criteria on Patients With Bone and Joint Infections in Outpatient Parenteral Antimicrobial Therapy
por: Marks, Michael, et al.
Publicado: (2020)

Assessment of ceftolozane/tazobactam degradation profile and toxicity data in elastomeric devices for continuous infusion via outpatient parenteral antimicrobial therapy (OPAT)
por: Gilchrist, Mark, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_pkno8tkms87h866ame8n57erbk